IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
April 27, 2023 08:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market...
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
March 06, 2023 08:45 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company,...
IRADIMED CORPORATION Issues Urgent Medical Device Correction
February 24, 2023 16:15 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 24, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a...
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend
February 02, 2023 08:00 ET
|
iRadimed Corporation
Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and...
IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
January 26, 2023 10:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market...
IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
January 18, 2023 08:00 ET
|
iRadimed Corporation
Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- IRADIMED...
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
November 03, 2022 07:00 ET
|
iRadimed Corporation
Revenue was $13.4 million and increased by 23%Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER...
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
October 27, 2022 08:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market...
IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
October 10, 2022 08:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5,...
IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors
October 06, 2022 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced the appointment of Hilda Scharen-Guivel to the Iradimed Board of...